Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.68
+0.02000.43%
Post-market: 4.680.00000.00%19:38 EDT
Volume:475.31K
Turnover:2.24M
Market Cap:146.44M
PE:-1.13
High:4.81
Open:4.71
Low:4.67
Close:4.66
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:0.74
T/O Rate:2.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.67
PE(LYR):-1.64

Loading ...

Autolus Therapeutics Earnings Call Highlights Growth Momentum

TIPRANKS
·
1 hour ago

Major Insider Move at CAMP4 Therapeutics Shakes Up Investor Buzz

TIPRANKS
·
Yesterday

Silexion Therapeutics Receives Nasdaq Delisting Notice, Plans Appeal

TIPRANKS
·
Yesterday

Tempest Therapeutics files to sell 8.91M shares of common stock for holders

TIPRANKS
·
Yesterday

Oruka Therapeutics Files $1 Billion Mixed Shelf

MT Newswires Live
·
Yesterday

Stoke Therapeutics Price Target Announced at $40.00/Share by JP Morgan

Dow Jones
·
Yesterday

Craig-Hallum Initiates Quince Therapeutics at Buy With $68 Price Target

MT Newswires Live
·
Aug 21

Ceryvyn Therapeutics Issues 7.2 Million Unquoted Long-Dated Options

TIPRANKS
·
Aug 21

Ipsen boosts hematology pipeline with Kartos Therapeutics acquisition

TIPRANKS
·
Aug 21

Alterity Therapeutics seeks ASX quotation for new ordinary shares

TIPRANKS
·
Aug 21

Chimeric Therapeutics Seeks ASX Quotation for 9.5 Million New Shares

TIPRANKS
·
Aug 21

HLS Therapeutics Earnings Call Highlights CV Growth

TIPRANKS
·
Aug 21

Bicycle Therapeutics Announces Board and Advisory Resignation

TIPRANKS
·
Aug 21

Qyuns Therapeutics (SEHK:2509) Stock Turns Profitable While Forecasts Cloud The Outlook

Simply Wall St.
·
Aug 21

Protagenic Therapeutics Advances PT00114 Toward U.S. IND

TIPRANKS
·
Aug 21

Sol-Gel Therapeutics: Steady SGT-610 Execution and Capital-Efficient Growth Strategy Drive Price Target Increase to $195 and Support Buy Rating

TIPRANKS
·
Aug 20

Vector Science and Therapeutics Files Patent for Orthopedic Regeneration Platform

TIPRANKS
·
Aug 20

Craig-Hallum bullish on Quince Therapeutics, initiates with a Buy

TIPRANKS
·
Aug 20

ProQR Therapeutics Price Target Announced at $8.00/Share by B of a Securities

Dow Jones
·
Aug 20

Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines

GlobeNewswire
·
Aug 20